Digital Health Technology Company Tempus Enrolls 2,500 Oncologists for Tempus Integrated Molecular Evaluation (TIME) Trial

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has reached a milestone in fully enrolling 2,500 oncologists into its Tempus Integrated Molecular Evaluation (TIME) Trial™ Program...

Emerging Decentralized Clinical Trials Mobile Platform Upstart Secures $25m and Fuel During Pivot from COVID-19

Medable, a Silicon Valley-based mobile app vendor seeking to decentralize clinical trials and reduce clinical trial timelines by 50%, has raised $25 million in funding to take their startup to the next level. The company seeks to help the drug development sector...

Pin It on Pinterest